Castleview Partners’s ChampionX CHX Stock Holding History

Castleview Partners’s Portfolio CHX Stock Details CHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-34,740	Closed	-$1.72K	–	762
2021 Q4	$1.72K	Buy	+34,740	New	+$817K	0.01%	303

Other funds holding CHX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Castleview Partners's CHX Position: Q1 2022 in Review

Castleview Partners sold out of ChampionX (CHX) in Q1 2022, closing a stake of 34,740 shares — an estimated $1.72K sold.

Castleview Partners first reported a position in CHX in Q4 2021 and held it in 1 quarter. The position peaked at $1.72K in Q4 2021. 333 funds tracked by Wall St. Rank hold CHX as of Q1 2022.

Castleview Partners reported no remaining ChampionX position as of Q1 2022 after selling out during the quarter.
Castleview Partners sold 34,740 ChampionX shares in Q1 2022, an estimated $1.72K.
Castleview Partners first reported a position in ChampionX in Q4 2021 and held it in 1 quarter.
Castleview Partners's ChampionX position peaked at $1.72K in Q4 2021.
333 funds tracked by Wall St. Rank held ChampionX as of Q1 2022.

Based on Castleview Partners's 13F filing for Q1 2022, filed 16 May 2022.